Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - AccuredReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Roivant Sciences (ROIV) Total Current Liabilities: 2021-2025

Historic Total Current Liabilities for Roivant Sciences (ROIV) over the last 5 years, with Mar 2025 value amounting to $149.4 million.

  • Roivant Sciences' Total Current Liabilities fell 75.94% to $133.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $133.9 million, marking a year-over-year decrease of 75.94%. This contributed to the annual value of $149.4 million for FY2025, which is 43.99% down from last year.
  • According to the latest figures from FY2025, Roivant Sciences' Total Current Liabilities is $149.4 million, which was up 5.60% from $141.5 million recorded in FY2024.
  • Roivant Sciences' Total Current Liabilities' 5-year high stood at $272.4 million during FY2023, with a 5-year trough of $141.5 million in FY2024.
  • Moreover, its 3-year median value for Total Current Liabilities was $244.9 million (2023), whereas its average is $215.0 million.
  • In the last 5 years, Roivant Sciences' Total Current Liabilities surged by 51.98% in 2022 and then slumped by 43.99% in 2025.
  • Yearly analysis of 5 years shows Roivant Sciences' Total Current Liabilities stood at $219.0 million in 2021, then reached $160.7 million in 2021, then declined by 15.80% to $184.4 million in 2022, then skyrocketed by 51.98% to $244.3 million in 2022, then soared by 47.77% to $272.4 million in 2023, then grew by 0.26% to $244.9 million in 2023, then declined by 2.09% to $266.8 million in 2024, then tumbled by 42.23% to $141.5 million in 2024, then slumped by 43.99% to $149.4 million in 2025.